Results 1 to 10 of about 1,228,259 (265)

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

open access: yesEClinicalMedicine, 2021
Background: A vaccine against SARS-CoV-2 is of high urgency. Here the safety and immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of SARS-CoV-2 are described.
Pablo Tebas   +37 more
doaj   +1 more source

Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL

open access: yesHuman Vaccines & Immunotherapeutics, 2021
VGX-3100 is an investigational DNA-based immunotherapy being developed as an alternative to surgery and ablation for cervical High-Grade Squamous Intraepithelial Lesion (HSIL) with the aim of preserving reproductive health while treating precancerous ...
Prakash K. Bhuyan   +8 more
doaj   +1 more source

Machine learning using longitudinal prescription and medical claims for the detection of non-alcoholic steatohepatitis (NASH)

open access: yesBMJ Health & Care Informatics, 2022
Objectives To develop and evaluate machine learning models to detect patients with suspected undiagnosed non-alcoholic steatohepatitis (NASH) for diagnostic screening and clinical management.Methods In this retrospective observational non-interventional ...
Orla Doyle   +10 more
doaj   +1 more source

Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Human telomerase reverse transcriptase (hTERT) is frequently classified as a ‘universal’ tumor associated antigen due to its expression in a vast number of cancers.
Laurent Humeau   +16 more
doaj   +1 more source

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis

open access: yesFrontiers in Pharmacology, 2022
Chitinase 1 (CHIT1) and chitinase 3-like-1 (CHI3L1), two representative members of 18-Glycosyl hydrolases family, are significantly implicated in the pathogenesis of various human diseases characterized by inflammation and remodeling.
Suh-Young Lee   +7 more
doaj   +1 more source

Multivalent DNA Vaccines as a Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses

open access: yesViruses, 2021
The emergence of multiple concurrent infectious diseases localized in the world creates a complex burden on global public health systems. Outbreaks of Ebola, Lassa, and Marburg viruses in overlapping regions of central and West Africa and the co ...
Jingjing Jiang   +16 more
doaj   +1 more source

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States

open access: yesAmerican Journal of Preventive Cardiology, 2021
Objective: We assessed national- and state-level geographic variations among patients with a history of ≥1 major atherosclerotic cardiovascular disease (ASCVD) event in: (1) the proportion of patients with retrospectively identified 2018 American College
Seth J. Baum   +7 more
doaj   +1 more source

Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis

open access: yesVaccines, 2020
: Background: Recurrent respiratory papillomatosis (RRP) is a rare disorder characterized by the generation of papillomas of the aerodigestive tract, usually associated with human papilloma virus (HPV) subtypes 6, 11.
Charu Aggarwal   +17 more
doaj   +1 more source

Abstracts: VI Internacional Dental Meeting, XXI Dental Meeting of Piracicaba – UNICAMP and ABOPREV Meeting/2014

open access: yesBrazilian Journal of Oral Sciences, 2010
.
International Dental Meeting VI   +2 more
doaj   +1 more source

Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100

open access: yesMolecular Therapy: Oncolytics, 2016
We have previously demonstrated the immunogenicity of VGX-3100, a multicomponent DNA immunotherapy for the treatment of Human Papillomavirus (HPV)16/18-positive CIN2/3 in a phase 1 clinical trial.
Matthew P Morrow   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy